Craneware (LON:CRW) Stock Price Passes Below 200 Day Moving Average – Time to Sell?

Craneware plc (LON:CRW) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,378.18 and traded as low as GBX 1,305.80. Craneware shares last traded at GBX 1,310, with a volume of 121,588 shares traded.

Analysts Set New Price Targets

Separately, Berenberg Bank cut their price target on Craneware from GBX 2,900 to GBX 2,600 and set a “buy” rating for the company in a research note on Friday, July 3rd. Four analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Craneware has an average rating of “Buy” and a consensus price target of GBX 2,222.75.

Craneware Price Performance

The firm has a market capitalization of £451.93 million, a PE ratio of 20.99 and a beta of 0.28. The business has a 50-day moving average of GBX 1,257.52 and a 200 day moving average of GBX 1,376.73. The company has a current ratio of 0.76, a quick ratio of 1.00 and a debt-to-equity ratio of 7.93.

Insiders Place Their Bets

In other news, insider Will Whitehorn bought 640 shares of Craneware stock in a transaction dated Friday, July 3rd. The stock was purchased at an average price of GBX 1,173 per share, for a total transaction of £7,507.20. Also, insider Keith Neilson bought 9,074 shares of the stock in a transaction dated Monday, July 6th. The stock was purchased at an average price of GBX 1,102 per share, with a total value of £99,995.48. 10.32% of the stock is owned by insiders.

Craneware Company Profile

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.